296 related articles for article (PubMed ID: 7471738)
1. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortion.
Christensen NJ; Bygdeman M; Gréen K
Contraception; 1983 Jan; 27(1):51-61. PubMed ID: 6839758
[TBL] [Abstract][Full Text] [Related]
3. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular administration of 16 phenoxy omega 17,18,19,20 tetranor PGE2 methyl sulfonylamide for pre-operative cervical dilatation in first trimester nulliparae.
Karim SM; Ilancheran A; Wun W; Ho TH; Ratnam SS
Prostaglandins Med; 1978 Jul; 1(1):71-5. PubMed ID: 715049
[TBL] [Abstract][Full Text] [Related]
5. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
[TBL] [Abstract][Full Text] [Related]
6. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
7. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
Christensen NJ; Bygdeman M
Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
[TBL] [Abstract][Full Text] [Related]
8. Use of different prostaglandin analogues for terminating pregnancy at different terms.
Manuilova IA
Acta Med Hung; 1986; 43(2):133-8. PubMed ID: 3588156
[TBL] [Abstract][Full Text] [Related]
9. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
10. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
Somell C; Olund A
Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
[TBL] [Abstract][Full Text] [Related]
11. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
12. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
13. Menstrual regulation by intramuscular injections of 16-phenoxy-tetranor PGE2 methyl sulfonylamide or vacuum aspiration. A randomized multicentre study. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation.
Br J Obstet Gynaecol; 1987 Oct; 94(10):949-56. PubMed ID: 2891372
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
[TBL] [Abstract][Full Text] [Related]
15. Termination of second trimester pregnancy with laminaria and intramuscular 15-methyl PGF2 alpha or 16-phenoxy-omega-17,18,19,20-tetranor PGE2 methyl sulfonylamide. A randomized multicenter study.
Bygdaman M
Int J Gynaecol Obstet; 1988 Feb; 26(1):129-35. PubMed ID: 2892729
[TBL] [Abstract][Full Text] [Related]
16. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
17. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
Brügger D; Dreher E
Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
[TBL] [Abstract][Full Text] [Related]
19. Cervical priming prior to dilatation and evacuation: a comparison of methods.
Lauersen NH; Den T; Iliescu C; Wilson KH; Graves ZR
Am J Obstet Gynecol; 1982 Dec; 144(8):890-4. PubMed ID: 7148920
[TBL] [Abstract][Full Text] [Related]
20. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
Nakano R; Hata H; Sasaki K; Yamoto M
Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
